Overview

Update
Total Equity Funding
$24.56M in 10 Rounds from 3 Investors
Most Recent Funding
$1.5M Grant on July 21, 2016
Headquarters:
Seattle, Washington
Description:
Kineta, a biotechnology company, aims at developing leading edge therapeutics in autoimmune disease, viral disease and chronic pain areas.
Founders:
Categories:
Therapeutics, Medical Device, Biotechnology
Website:
http://www.kinetabio.com
Social:

Company Details

Update

Kineta, Inc., a biotechnology company, engages in the discovery and development of antiviral therapies and immune modulating drugs for the treatment of RNA viruses that include hepatitis C, influenza, west nile virus, and common cold. It offers ShK Analogs for treatment of multiple sclerosis and autoimmune diseases; and RIG-I Pathway, a molecular on/off switch that triggers the human body's immune defenses against virus infection. Kineta, Inc. was formerly known as Lecura, Inc. The company was founded in 2007 and is based in Seattle, Washington.

Funding Rounds (12) - $27.81M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jul, 2016$1.5M / Grant0
Jun, 2016$1.75M / Debt Financing0
May, 2016$760.78k / Venture0
Dec, 2015$7M / Series B0
May, 2015undisclosed amount / Venture1
Jan, 2015$7M / Series B1
May, 2014$1.63M / Venture0
Mar, 2014undisclosed amount / Undisclosed1
Oct, 2013$760.5k / Venture0
Aug, 2012$5.76M / Venture0
Jul, 2010$709.32k / Venture0
Jan, 2010$942.46k / Venture0

Current Team (5)

Update

Offices/Locations (1)

Update
  • Headquarters

    219 Terry Ave N

    Suite 300

    Seattle, Washington 98109-5208

    United States

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos